May 28, 2021
The Ministry of Health, Labor and Welfare (MHLW) updated its COVID-19 treatment guide on May 26, adding Eli Lilly’s JAK inhibitor Olumiant (baricitinib) to the list of medicines approved in Japan to treat the disease. In April, the MHLW granted...read more